MIRA PHARMACEUTICALS, INC. cotiza a 0.70 USD y tiene una capitalización bursátil de $30M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that…
| Periodo | 2025-11 | 2025-08 | 2025-05 | 2025-03 |
|---|---|---|---|---|
| Real | $-0.07 | $-0.09 | $-0.11 | $-0.14 |
| Estimado | $-0.08 | $-0.13 | $-0.14 | $-0.23 |
| Sorpresa | +12.5% | +30.8% | +21.4% | +39.1% |
| Métrica | MIRA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -100.5% | -40.4% | -60.1% |
| ROA | -94.1% | -32.0% | -62.1% |
| Current Ratio | 15.75 | 2.84 | +12.91 |
| Debt / Equity | — | 0.28 | — |